Home » Topics » BioWorld Science

BioWorld Science
RSS

CTA approval for ARGX-112 triggers milestone payment to Argenx

April 13, 2018

Mutation in FPN1 gene found to protect against malaria infection

April 12, 2018

Arbutus Biopharma and Roivant Sciences launch jointly owned Genevant Sciences

April 12, 2018

Pfizer initiates comparative phase III study of aztreonam/avibactam in Gram-negative infections

April 12, 2018

University of Oxford initiates phase I trial of MERS-CoV vaccine

April 12, 2018

Destiny's discussions with FDA clarify overall clinical trial plans for XF-73

April 12, 2018

Fujifilm Kyowa Kirin Biologics licenses rights to Mylan to commercialize adalimumab biosimilar

April 12, 2018

CNRS, Universite d'Orleans identify novel agents for filovirus infections

April 12, 2018

Entasis Therapeutics patents new beta-lactamase inhibitors

April 12, 2018

Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome

April 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026